Price $6.09 |
Market Cap
182.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.62
|
P/S
4.97
|
Dividend %
-
|
|
P/CF
12.5
|
P/FCF
-
|
Op. Cash Flow
-8.8K
|
FCF
-0.3
|
|
Op. Margin
-23.30%
|
Net Margin
-24.00%
|
ROE
-18.80%
|
ROI
-26.00%
|
|
ROA
-13.20%
|
EPS Growth
62.20%
|
Current Ratio
2.5
|
Debt/Equity
23.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Emmaus Life Sciences Inc (EMMA) | $1.44 | - | - | 75M | Strong Buy |
| Cannabis Sativa Inc (CBDS) | $0.21 | - | - | 6M | Strong Buy |
| Magellan Health Inc (MGLN) | $94.99 | - | - | 2.5B | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $64.93 | - | 3.50% | 138.77B | Strong Buy |
| Avanos Medical Inc (AVNS) | $32.67 | - | - | 1.66B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
